← Back to Search

Not Applicable

Natural Treatment for Seborrheic Dermatitis

Phase 1 & 2
Waitlist Available
Led By Lucy Bilaver, PHD
Research Sponsored by Ann & Robert H Lurie Children's Hospital of Chicago
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights

Study Summary

This study is evaluating whether a topical treatment for dry scalp conditions is safe and effective in improving dry scalp conditions.

Eligible Conditions
  • Seborrheic Dermatitis
  • Eczema

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Improvement of patients erythema, scaling, and pruritus
Safety/patients comfort of the product using Overall Safety Score assessment, a 4 point assessment.
Secondary outcome measures
Scalp structure
Quality of Life change

Trial Design

2Treatment groups
Experimental Treatment
Group I: ChildrenExperimental Treatment1 Intervention
All children in the study will receive the treatment for dry scalp.
Group II: AdultsExperimental Treatment1 Intervention
All adults in the study will receive the treatment for dry scalp.

Find a Location

Logistics

Participation is compensated

You will be compensated for participating in this trial.

Who is running the clinical trial?

Feinberg School of Medicine, Northwestern UniversityOTHER
33 Previous Clinical Trials
12,184 Total Patients Enrolled
Ann & Robert H Lurie Children's Hospital of ChicagoLead Sponsor
258 Previous Clinical Trials
5,189,070 Total Patients Enrolled
Northwestern University Feinberg School of MedicineOTHER
38 Previous Clinical Trials
14,811 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~10 spots leftby Apr 2025